Cargando…

Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?

Several serine proteases have been linked to autoimmune disorders and tumour initiation although the mechanisms are not fully understood. Activation of the kynurenine pathway enzyme indoleamine-2,3-dioxygenase (IDO1) modulates cellular activity in the brain, tolerogenesis in the immune system and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Clanchy, Felix I. L., Huang, Yi-Shu, Ogbechi, Joy, Darlington, L. Gail, Williams, Richard O., Stone, Trevor W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964980/
https://www.ncbi.nlm.nih.gov/pubmed/35371018
http://dx.doi.org/10.3389/fimmu.2022.832989
_version_ 1784678332019769344
author Clanchy, Felix I. L.
Huang, Yi-Shu
Ogbechi, Joy
Darlington, L. Gail
Williams, Richard O.
Stone, Trevor W.
author_facet Clanchy, Felix I. L.
Huang, Yi-Shu
Ogbechi, Joy
Darlington, L. Gail
Williams, Richard O.
Stone, Trevor W.
author_sort Clanchy, Felix I. L.
collection PubMed
description Several serine proteases have been linked to autoimmune disorders and tumour initiation although the mechanisms are not fully understood. Activation of the kynurenine pathway enzyme indoleamine-2,3-dioxygenase (IDO1) modulates cellular activity in the brain, tolerogenesis in the immune system and is a major checkpoint in cancer development. We now report that IDO1 mRNA and IDO1 protein expression (generating kynurenine) are induced in human monocyte-derived macrophages by several chymotryptic serine proteases with direct links to tumorigenesis, including Prostate Specific Antigen (PSA), CD26 (Dipeptidyl-peptidase-4, CD26/DPP-4), High Temperature Requirement protein-A (HtrA), and the bacterial virulence factor subtilisin. These proteases also induce expression of the pro-inflammatory cytokine genes IL1B and IL6. Other serine proteases tested: bacterial glu-C endopeptidase and mammalian Pro-protein Convertase Subtilase-Kexin-3 (PCSK3, furin), urokinase plasminogen activator (uPA), cathepsin G or neutrophil elastase, did not induce IDO1, indicating that the reported effects are not a general property of all serine proteases. The results represent a novel mechanism of activating immunosuppressive IDO1 and inducing kynurenine generation which, together with the production of inflammatory cytokines, would contribute to tumour initiation and progression, providing a new target for drug development. In addition, the proteasomal S20 serine protease inhibitor carfilzomib, used in the treatment of myeloma, prevented the induction of IDO1 and cytokine gene expression, potentially contributing to its clinical anti-cancer activity.
format Online
Article
Text
id pubmed-8964980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89649802022-03-31 Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression? Clanchy, Felix I. L. Huang, Yi-Shu Ogbechi, Joy Darlington, L. Gail Williams, Richard O. Stone, Trevor W. Front Immunol Immunology Several serine proteases have been linked to autoimmune disorders and tumour initiation although the mechanisms are not fully understood. Activation of the kynurenine pathway enzyme indoleamine-2,3-dioxygenase (IDO1) modulates cellular activity in the brain, tolerogenesis in the immune system and is a major checkpoint in cancer development. We now report that IDO1 mRNA and IDO1 protein expression (generating kynurenine) are induced in human monocyte-derived macrophages by several chymotryptic serine proteases with direct links to tumorigenesis, including Prostate Specific Antigen (PSA), CD26 (Dipeptidyl-peptidase-4, CD26/DPP-4), High Temperature Requirement protein-A (HtrA), and the bacterial virulence factor subtilisin. These proteases also induce expression of the pro-inflammatory cytokine genes IL1B and IL6. Other serine proteases tested: bacterial glu-C endopeptidase and mammalian Pro-protein Convertase Subtilase-Kexin-3 (PCSK3, furin), urokinase plasminogen activator (uPA), cathepsin G or neutrophil elastase, did not induce IDO1, indicating that the reported effects are not a general property of all serine proteases. The results represent a novel mechanism of activating immunosuppressive IDO1 and inducing kynurenine generation which, together with the production of inflammatory cytokines, would contribute to tumour initiation and progression, providing a new target for drug development. In addition, the proteasomal S20 serine protease inhibitor carfilzomib, used in the treatment of myeloma, prevented the induction of IDO1 and cytokine gene expression, potentially contributing to its clinical anti-cancer activity. Frontiers Media S.A. 2022-03-15 /pmc/articles/PMC8964980/ /pubmed/35371018 http://dx.doi.org/10.3389/fimmu.2022.832989 Text en Copyright © 2022 Clanchy, Huang, Ogbechi, Darlington, Williams and Stone https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Clanchy, Felix I. L.
Huang, Yi-Shu
Ogbechi, Joy
Darlington, L. Gail
Williams, Richard O.
Stone, Trevor W.
Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title_full Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title_fullStr Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title_full_unstemmed Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title_short Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
title_sort induction of ido1 and kynurenine by serine proteases subtilisin, prostate specific antigen, cd26 and htra: a new form of immunosuppression?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964980/
https://www.ncbi.nlm.nih.gov/pubmed/35371018
http://dx.doi.org/10.3389/fimmu.2022.832989
work_keys_str_mv AT clanchyfelixil inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression
AT huangyishu inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression
AT ogbechijoy inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression
AT darlingtonlgail inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression
AT williamsrichardo inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression
AT stonetrevorw inductionofido1andkynureninebyserineproteasessubtilisinprostatespecificantigencd26andhtraanewformofimmunosuppression